Related Experiment Video
Updated: May 31, 2026
07:51
Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography
Published on: September 22, 2011
A potential calcium antagonist and its antihypertensive effects
Yan Zhang1, YanJun Cao, QunLi Wang
1School of Medicine, Xi'an Jiaotong University, Xi'an, PR China; The Mental Health Center of Xi'an, Xi'an, PR China.
Fitoterapia
|June 18, 2011
Summary
Imperatorin (Imp) effectively lowers blood pressure in spontaneously hypertensive rats by blocking L-type calcium channels. This natural compound shows potential as a novel antihypertensive drug.
Area of Science:
- Pharmacology
- Cardiovascular Research
- Natural Products Chemistry
Background:
- Hypertension remains a significant global health concern.
- Existing antihypertensive drugs have limitations and side effects.
- Natural compounds are increasingly explored for therapeutic potential.
Purpose of the Study:
- To evaluate the antihypertensive effect of Imperatorin (Imp).
- To investigate the mechanism of action of Imp, specifically its interaction with calcium channels.
- To assess the potential of Imp as a novel antihypertensive agent.
Main Methods:
- In vivo studies using spontaneously hypertensive rats (SHRs).
- In vitro assays including aortic ring relaxation and L-type calcium channel current measurements.
- Cell membrane chromatography and protein-drug docking simulations.
Main Results:
- Imperatorin significantly reduced blood pressure in SHRs.
- Imp demonstrated calcium antagonism, relaxing aortic rings.
- Measurements confirmed Imp's ability to inhibit L-type calcium channel currents and intracellular calcium ion rise.
- Chromatographic and docking studies indicated Imp targets L-type calcium channels, similar to known drugs like nitrendipine and verapamil.
Conclusions:
- Imperatorin possesses significant antihypertensive properties.
- The mechanism involves the blockade of L-type calcium channels.
- Imperatorin represents a promising candidate for the development of new antihypertensive therapies.
Related Concept Videos
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...